Zentiva
Czech Republic · Pharma & Healthcare
LeaveRussia detail: Continue Operations
Zentiva is a pharmaceutical company based in Prague, Czech Republic. The company is developing, manufacturing and marketing a wide range of generic and OTC products. Zentiva employs more than 4 700 people across Europe and has three manufacturing sites, in Prague, Bucharest and Ankleshwar.
Decision trail
Decision date 28/03/2025 · Reference ↗
Received revenues in Russia in 2022-2024. Zentiva sells operations in Russia and CIS markets, no details disclosed officially so far. Revenue increased in 2024 vs 2023 by more than +30%.
Local stats (LeaveRussia)
Assets(RF), mln.USD
47
Capital(RF), mln.USD
17
Revenue(RF), mln.USD
89
Staff(RF), 2021
173
Taxes(RF), mln.USD
3
Glob.Revenue, mln.USD
50261
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional